FDA approves first treatment for COVID-19

22 October 2020 - Today, the U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult ...

Read more →

Trump promised seniors drug discount cards. They may be illegal.

22 October 2020 - A proposal announced by President Trump last month was to send older Americans $200 discount cards to ...

Read more →

Remdesivir’s hefty price tag ignores NIH investment in its creation

22 October 2020 - Throughout the Democratic presidential primary, candidates cast a spotlight on the broken U.S. health care system ...

Read more →

Leo Pharma announces U.S. FDA approval for Enstilar (calcipotriene and betamethasone dipropionate) foam U.S. Prescribing Information update to include data in long-term use in plaque psoriasis treatment

22 October 2020 - U.S. Prescribing Information updated to include PSO-LONG clinical trial data concerning long-term use (52 weeks) of twice-weekly ...

Read more →

AppliedVR receives FDA breakthrough device designation to treat pain with digital therapeutic

21 October 2020 - AppliedVR today announced its EaseVRx product received breakthrough device designation from the U.S. FDA for treating ...

Read more →

FDA approves fewer generics in FY2020, ending record streak

21 October 2020 - After four straight years of posting record numbers of abbreviated new drug application approvals, the US ...

Read more →

U.S. FDA grants fast track designation for ASP0367/MA-0211, a selective PPARδ modulator being developed for the treatment of primary mitochondrial myopathies

20 October 2020 - Astellas Pharma today announced that the U.S. FDA has granted fast track designation for the development ...

Read more →

A prescription for America’s drug pricing problem?

21 October 2020 - Sky-high prescription drug costs remains one of the most hotly contested issues in healthcare today.  ...

Read more →

COVID-19 vaccines to be stored secretly under tight security

21 October 2020 - Drug makers and others plan to use fake shipments and GPS trackers to prevent potential thefts. ...

Read more →

Trump’s antibody ‘cure’ will be in short supply

20 October 2020 - All the weak points of American health care — testing delays, communication breakdowns, inequity — are working ...

Read more →

ICER posts draft scoping document for the assessment of Alzheimer’s disease

21 October 2020 - Document open to public comment until 10 November 2020. ...

Read more →

TG Therapeutics announces fast track designation granted by the FDA to ublituximab in combination with umbralisib for the treatment of adult patients with chronic lymphocytic leukaemia

21 October 2020 - TG Therapeutics today announced that the U.S. FDA has granted fast track designation to the combination of ...

Read more →

Premiums for HealthCare.gov plans are lower for third consecutive year

19 October 2020 - Increased issuer participation, competition and greater choice on the Federal Health Insurance Exchanges. ...

Read more →

Xeris Pharmaceuticals granted fast track designation by the FDA for its novel concentrated diazepam formulation (XP-0863) for injection

20 October 2020 - Xeris Pharmaceuticals today announced it was granted fast track designation by the FDA for the investigation ...

Read more →

How the FDA stood up to the President

20 October 2020 - Dr. Stephen Hahn, the F.D.A. commissioner, occupies a fraught position, caught between pressure from the White House ...

Read more →